| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H24Cl2N2O |
| Molecular Weight | 391.334 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN([C@H](CN1CCCC1)C2=CC=CC=C2)C(=O)CC3=CC(Cl)=C(Cl)C=C3
InChI
InChIKey=AEJOEPSMZCEYJN-HXUWFJFHSA-N
InChI=1S/C21H24Cl2N2O/c1-24(21(26)14-16-9-10-18(22)19(23)13-16)20(15-25-11-5-6-12-25)17-7-3-2-4-8-17/h2-4,7-10,13,20H,5-6,11-12,14-15H2,1H3/t20-/m1/s1
| Molecular Formula | C21H24Cl2N2O |
| Molecular Weight | 391.334 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 0.04 nM [Ki] | |||
| 53.0 nM [Ki] | |||
| 24.0 nM [Ki] | |||
| 26.0 nM [IC50] |
